The purpose of stability testing data and programs is to ensure a drug product’s safety and efficacy remain within its specifications throughout the shelf-life. To develop suitable analytical methods to detect and quantify degradation products, drug manufacturers should conduct forced-degradation studies.
Anna Thabit-Jones, Stability Manager at PCI Services, recently addressed vital points of the process for stability studies with Meg Rivers in Pharmaceutical Technology.